Arodiwe Ejikeme Benneth, Arodiwe Ijeoma Ogugua, Okoronkwo Ijeoma
Department of Medicine, College of Medicine, University of Nigeria, Enugu Campus.
Department of Health Administration and Management, Faculty of Health Sciences and Technology, University of Nigeria, Enugu Campus.
Ethiop J Health Sci. 2024 Nov;34(6):536-542. doi: 10.4314/ejhs.v34i6.14.
Chronic kidney disease (CKD) is a growing global health issue, particularly in low- and middle-income countries. The cost of managing CKD is high, yet there is limited information available regarding this burden in sub-Saharan Africa.
This descriptive cross-sectional study involved 100 CKD patients at the Renal Unit of a hospital between July and December 2019. Data was collected using a pre-tested, semi-structured questionnaire. Frequencies, means, percentages, standard deviations, medians, and interquartile ranges were used for data analysis. ANOVA and chi-square tests were also employed to assess correlations.
The mean total monthly cost of treatment was 135,199 ± 81,060 Naira ($417 ± 250), with direct and indirect costs averaging 127,565 ± 76,139.8 Naira ($393 ± 235) and 8,309 ± 16,735 Naira ($26 ± 52), respectively. Direct costs accounted for 94% of the total illness cost, with hemodialysis alone representing 86.1% of the total cost. There were no significant differences in treatment costs across socioeconomic classes. Out-of-pocket spending accounted for 88% of healthcare expenses.
The cost of CKD management is high, with hemodialysis comprising the majority of the cost. Most patients pay out of pocket It is recommended that a comprehensive health insurance scheme be implemented, especially to cover hemodialysis treatment.
慢性肾脏病（CKD）是一个日益严重的全球健康问题，在低收入和中等收入国家尤为突出。管理CKD的成本很高，但关于撒哈拉以南非洲地区这一负担的可用信息有限。
这项描述性横断面研究于2019年7月至12月在一家医院的肾脏科纳入了100例CKD患者。使用预先测试的半结构化问卷收集数据。频率、均值、百分比、标准差、中位数和四分位间距用于数据分析。还采用方差分析和卡方检验来评估相关性。
每月治疗总费用平均为135,199 ± 81,060奈拉（417 ± 250美元），直接成本和间接成本分别平均为127,565 ± 76,139.8奈拉（393 ± 235美元）和8,309 ± 16,735奈拉（26 ± 52美元）。直接成本占疾病总成本的94%，仅血液透析就占总成本的86.1%。不同社会经济阶层的治疗成本无显著差异。自付费用占医疗费用的88%。
CKD管理成本很高，血液透析占成本的大部分。大多数患者自掏腰包。建议实施全面的健康保险计划，特别是覆盖血液透析治疗。
